The PBA Advisory Committee has introduced a risk share (cap) arrangement that may affect the accessibility of new therapies for Atopic Dermatitis. Join us to learn more about RSAs and what clinicians can do to improve their patient's quality of life.
Join us for an engaging conversation with Professor John Kelly and Associate Professor Robert Kelly as they generously recount their professional odysseys, offering insights into their experiences as dermatologists.
This workshop will provide an overview of atopic dermatitis detailing triggers in disease aetiology, individually tailored treatment, the role of topical corticosteroids in management, emerging therapies and when care escalation is required.
Join Dr Andrew Pink and A/Prof Peter Foley as they explore the treat-to-target strategy and algorithm, a dynamic framework adjusting to evolving therapies. Discover refinements in chronic skin condition management.
Join us for a captivating session in our Legacy Series as we delve into the distinguished professional journey of Dr Michael Rich, a renowned specialist in dermatology.
The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event.
The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event in Sydney.
The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event in Brisbane.
Join us for our exclusive Masterclass series, tailored for nurses and led by Sue Anderson, Clinical Nurse Consultant & Advanced Targeted Therapies Education Lead. Sessions will be held every Thursday from 21st September to 2nd November, running from 12:30 pm to 1:30 pm.
Can't Attend the 32nd EADV Congress in Berlin? Join our Summary Highlights session from the comfort of your home! Join Dr Matthew Howard as he discusses the 2023 EADV as presented at the 2023 Congress in Berlin and the relevance of this information to Australian clinicians during a Q+A discussion.
The Australasian Dermatology Registry (ADR) is a national collaboration between dermatologists, facilitated and coordinated by the Skin Health Institute. This information session features a series of experts for each disease state that is currently a part of the ADR.
Join Professor Falk G. Bechara as he discusses the most recent research, medical, and surgical treatments for Hidradenitis Suppurativa.
Monday: 8am – 6pm
Tuesday: 8am – 6pm
Wednesday: 8am – 6pm
Thursday: 8am – 5pm
Friday: 8am – 5pm
